New Jersey § 18a:40-12

§ 18a:40-12.

a. Each board of education or chief school administrator of a nonpublic school shall

develop a policy in accordance with the guidelines established by the Department of

Education pursuant to section 4 of P.L.2019, c. 118 ( C.18A:40-12.31 ) for the emergency administration of hydrocortisone sodium succinate through appropriate

delivery devices and equipment to a pupil for adrenal insufficiency provided that: (1) the parents or guardians of the pupil provide to the board of education or chief

school administrator of a nonpublic school written authorization for the administration

of hydrocortisone sodium succinate; (2) the parents or guardians of the pupil provide to the board of education or chief

school administrator of a nonpublic school written orders from the physician or advanced

practice nurse that the pupil requires the administration of hydrocortisone sodium

succinate for adrenal insufficiency; (3) the board or chief school administrator of a nonpublic school informs the parents

or guardians of the pupil in writing that the district and its employees or agents

or the nonpublic school and its employees or agents shall have no liability as a result

of any injury arising from the administration of hydrocortisone sodium succinate; (4) the parents or guardians of the pupil sign a statement acknowledging their understanding

that the district or the nonpublic school shall have no liability as a result of any

injury arising from the administration of hydrocortisone sodium succinate to the pupil

and that the parents or guardians shall indemnify and hold harmless the district and

its employees or agents or the nonpublic school and its employees or agents against

any claims arising out of the administration of hydrocortisone sodium succinate;

and (5) the permission is effective for the school year for which it is granted and is

renewed for each subsequent school year upon fulfillment of the requirements in paragraphs

(1) through (4) of this subsection. b. The policy developed by a board of education or chief school administrator of a

nonpublic school shall require: (1) the placement of a pupil's prescribed hydrocortisone sodium succinate in a secure

but unlocked location easily accessible by the school nurse and designees to ensure

prompt availability in the event of emergency situations at school or at a school-sponsored

function. The location of the hydrocortisone sodium succinate shall be indicated on the pupil's

emergency care plan. Back-up hydrocortisone sodium succinate, provided by the pupil's parent or guardian,

shall also be available at the school if needed; (2) the school nurse or designee to be promptly available on site at the school and

school-sponsored functions in the event of an emergency; and (3) the transportation of the pupil to a hospital emergency room by emergency services

personnel after the administration of hydrocortisone sodium succinate, even if the

pupil's symptoms appear to have resolved.